Location: San Francisco, CA
CIK: 0001802967 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value: $109M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| TWST | Twist Bioscience Corporation | 828,815 | $30.55M | 27.9% | $36.86 * | $23.40 | -1.2% | Common Stock | 90184D100 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 130,529 | $30.2M | 27.6% | $231.38 * | $130.16 | +34.4% | Common Stock | 558868105 |
| TSLA | Tesla, Inc. | 86,250 | $21.43M | 19.6% | $248.49 * | $212.32 | +11.9% | Common Stock | 88160R101 |
| H | Hyatt Hotels Corporation | 70,000 | $9.129M | 8.4% | $130.41 * | $76.75 | +46.5% | Class B Common Stock | 448579102 |
| OUST | Ouster, Inc. | 1,125,316 | $8.632M | 7.9% | $7.67 * | $5.54 | -5.3% | Common Stock | 68989M202 |
| MASS | 908 Devices Inc. | 568,981 | $6.384M | 5.8% | $11.22 * | $58.41 | -88.3% | Common Stock | 65443P102 |
| WRBY | Warby Parker Inc. | 134,473 | $1.897M | 1.7% | $14.11 * | $53.77 | -76.8% | Class A Common Stock | 93403J106 |
| — | Ginkgo Bioworks Holdings, Inc. | 227,354 | $385K | 0.4% | $1.69 | $0.00 | — | Class A Common Stock | 37611X100 |
| — | Benson Hill, Inc. | 1,774,681 | $309K | 0.3% | $0.17 | $7.13 | — | Common Stock | 082490103 |
| SONDQ | Sonder Holdings Inc. | 80,188 | $272K | 0.2% | $3.39 * | $9.74 | -40.7% | Class A Common Stock | 83542D300 |
| DNLI | Denali Therapeutics Inc. | 3,042 | $66,000 | 0.1% | $21.70 * | $19.81 | 0.0% | Common Stock | 24823R105 |
| SRRK | Scholar Rock Holding Corporation | 2,842 | $54,000 | 0.0% | $19.00 * | $12.43 | 0.0% | Common Stock | 80706P103 |